Old Web
English
Sign In
Acemap
>
authorDetail
>
Anjelika Gasilina
Anjelika Gasilina
Hospital Research Foundation
Cancer research
Chemistry
Cancer
Programmed cell death
Lamellipodium
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia.
2021
Leukemia
Shailaja Hegde
Anjelika Gasilina
Mark Wunderlich
Yuan Lin
Marcel Buchholzer
Oliver H.F. Krumbach
Mohammad Akbarzadeh
Mohammad Reza Ahmadian
William L. Seibel
Yi Zheng
John P. Perentesis
Benjamin Mizukawa
Lisa M. Privette Vinnedge
Jose A. Cancelas
Nicolas Nassar
Show All
Source
Cite
Save
Citations (0)
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.
2020
PLOS ONE
Anjelika Gasilina
Gurdat Premnauth
Purujit N. Gurjar
Jacek Biesiada
Shailaja Hegde
David Milewski
Gang Ma
Tanya V. Kalin
Edward J. Merino
Jarek Meller
William L. Seibel
Jose A. Cancelas
Lisa Privette Vinnedge
Nicolas N. Nassar
Show All
Source
Cite
Save
Citations (1)
IODVA1, a Guanidinobenzimidazole Derivative with in vivo Activity Against Ras-Driven Cancer Models
2019
Social Science Research Network
Anjelika Gasilina
Gurdat Premnauth
Purujit N. Gurjar
Jacek Biesiada
Shailaja Hegde
David Milewski
Gang Ma
Tanya V. Kalin
Edward J. Merino
Jarek Meller
William L. Seibel
Jose A. Cancelas
Lisa M. Privette Vinnedge
Nicolas N. Nassar
Show All
Source
Cite
Save
Citations (0)
1